(ZION) Zions Bancorporation - Overview
Stock: Commercial Loans, Retail Banking, Wealth Management, Treasury Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.38% |
| Yield on Cost 5y | 5.39% |
| Yield CAGR 5y | 5.14% |
| Payout Consistency | 93.5% |
| Payout Ratio | 29.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.6% |
| Relative Tail Risk | -11.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.48 |
| Alpha | -0.27 |
| Character TTM | |
|---|---|
| Beta | 1.190 |
| Beta Downside | 1.604 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.03% |
| CAGR/Max DD | 0.19 |
Description: ZION Zions Bancorporation January 06, 2026
Zions Bancorporation (NASDAQ: ZION) is a regional bank headquartered in Salt Lake City, Utah, operating across eleven western states through subsidiaries such as Zions Bank, California Bank & Trust, Amegy Bank, and others. Its product suite spans commercial and small-business banking, retail banking, wealth management, and capital-markets services, including loan syndications, FX, and CMBS conduit financing.
The bank’s business is organized into distinct segments: (1) commercial & small-business banking, delivering industrial loans, municipal finance, and cash-management solutions; (2) retail banking, offering residential mortgages, HELOCs, consumer loans, and deposit accounts; and (3) wealth management, providing investment advisory, fiduciary, and estate-planning services. This diversification aims to smooth earnings across credit cycles.
Recent KPIs (Q1 2024) show a net interest margin of 3.12%-slightly above the regional-bank average of ~2.9%-and loan growth of 5.4% YoY, driven largely by commercial real-estate and small-business portfolios. Deposits rose 3.8% YoY to $47 billion, supporting a loan-to-deposit ratio of 73%, which remains comfortably below the industry stress threshold of 90%.
Key economic drivers for ZION include the Fed’s policy stance (higher rates boost NIM but increase credit-risk pressure on commercial real-estate borrowers) and western-U.S. housing market dynamics, where modest price appreciation sustains mortgage demand. The regional-bank sector is also sensitive to credit-quality trends in the energy-intensive states where ZION has exposure.
For a deeper, data-rich assessment of ZION’s valuation and risk profile, you might explore the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 899.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.76 > 1.0 |
| NWC/Revenue: 316.6% < 20% (prev -1337 %; Δ 1654 % < -1%) |
| CFO/TA 0.01 > 3% & CFO 1.07b > Net Income 899.0m |
| Net Debt (3.89b) to EBITDA (1.26b): 3.09 < 3 |
| Current Ratio: 6.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (147.1m) vs 12m ago -0.14% < -2% |
| Gross Margin: 67.05% > 18% (prev 0.61%; Δ 6644 % > 0.5%) |
| Asset Turnover: 5.56% > 50% (prev 5.61%; Δ -0.05% > 0%) |
| Interest Coverage Ratio: 0.54 > 6 (EBITDA TTM 1.26b / Interest Expense TTM 1.56b) |
Altman Z'' 1.58
| A: 0.18 (Total Current Assets 18.76b - Total Current Liabilities 3.10b) / Total Assets 88.99b |
| B: 0.08 (Retained Earnings 7.33b / Total Assets 88.99b) |
| C: 0.01 (EBIT TTM 836.0m / Avg Total Assets 88.88b) |
| D: 0.09 (Book Value of Equity 7.11b / Total Liabilities 81.81b) |
| Altman-Z'' Score: 1.58 = BB |
What is the price of ZION shares?
Over the past week, the price has changed by +8.98%, over one month by +7.10%, over three months by +28.50% and over the past year by +15.87%.
Is ZION a buy, sell or hold?
- StrongBuy: 3
- Buy: 2
- Hold: 15
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the ZION price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 66.1 | 1.3% |
| Analysts Target Price | 66.1 | 1.3% |
| ValueRay Target Price | 69.5 | 6.5% |
ZION Fundamental Data Overview February 02, 2026
P/E Forward = 9.7182
P/S = 2.6692
P/B = 1.2434
P/EG = 1.7348
Revenue TTM = 4.94b USD
EBIT TTM = 836.0m USD
EBITDA TTM = 1.26b USD
Long Term Debt = 1.47b USD (from longTermDebt, two quarters ago)
Short Term Debt = 3.10b USD (from shortTermDebt, last quarter)
Debt = 4.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.89b USD (from netDebt column, last quarter)
Enterprise Value = -5.34b USD (8.85b + Debt 4.58b - CCE 18.76b)
Interest Coverage Ratio = 0.54 (Ebit TTM 836.0m / Interest Expense TTM 1.56b)
EV/FCF = -5.55x (Enterprise Value -5.34b / FCF TTM 961.0m)
FCF Yield = -18.01% (FCF TTM 961.0m / Enterprise Value -5.34b)
FCF Margin = 19.44% (FCF TTM 961.0m / Revenue TTM 4.94b)
Net Margin = 18.18% (Net Income TTM 899.0m / Revenue TTM 4.94b)
Gross Margin = 67.05% ((Revenue TTM 4.94b - Cost of Revenue TTM 1.63b) / Revenue TTM)
Gross Margin QoQ = 70.90% (prev 64.80%)
Tobins Q-Ratio = -0.06 (set to none) (Enterprise Value -5.34b / Total Assets 88.99b)
Interest Expense / Debt = 7.82% (Interest Expense 358.0m / Debt 4.58b)
Taxrate = 22.42% (76.0m / 339.0m)
NOPAT = 648.6m (EBIT 836.0m * (1 - 22.42%))
Current Ratio = 6.04 (Total Current Assets 18.76b / Total Current Liabilities 3.10b)
Debt / Equity = 0.64 (Debt 4.58b / totalStockholderEquity, last quarter 7.18b)
Debt / EBITDA = 3.09 (Net Debt 3.89b / EBITDA 1.26b)
Debt / FCF = 4.05 (Net Debt 3.89b / FCF TTM 961.0m)
Total Stockholder Equity = 6.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.01% (Net Income 899.0m / Total Assets 88.99b)
RoE = 13.33% (Net Income TTM 899.0m / Total Stockholder Equity 6.74b)
RoCE = 10.18% (EBIT 836.0m / Capital Employed (Equity 6.74b + L.T.Debt 1.47b))
RoIC = 8.46% (NOPAT 648.6m / Invested Capital 7.66b)
WACC = 8.86% (E(8.85b)/V(13.42b) * Re(10.30%) + D(4.58b)/V(13.42b) * Rd(7.82%) * (1-Tc(0.22)))
Discount Rate = 10.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.18%
[DCF Debug] Terminal Value 78.52% ; FCFF base≈691.8m ; Y1≈853.4m ; Y5≈1.45b
Fair Price DCF = 115.3 (EV 20.91b - Net Debt 3.89b = Equity 17.02b / Shares 147.7m; r=8.86% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 14.57 | EPS CAGR: 7.06% | SUE: 0.59 | # QB: 0
Revenue Correlation: 83.82 | Revenue CAGR: 16.97% | SUE: 2.71 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.41 | Chg30d=+0.030 | Revisions Net=+11 | Analysts=19
EPS current Year (2026-12-31): EPS=6.19 | Chg30d=+0.107 | Revisions Net=+17 | Growth EPS=+3.0% | Growth Revenue=+2.6%
EPS next Year (2027-12-31): EPS=6.55 | Chg30d=+0.114 | Revisions Net=+13 | Growth EPS=+5.8% | Growth Revenue=+4.6%